» Articles » PMID: 18188010

The Voice of the Patients: Allergic Rhinitis is Not a Trivial Disease

Overview
Date 2008 Jan 12
PMID 18188010
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Patient and physician perspectives on the impact of allergic rhinitis have previously been studied in the general population. We evaluated the burden of allergic rhinitis among patients from the members of European allergy patient organizations. The Patient Voice Allergy Survey was a quantitative, self-completion survey of 3562 patients with allergic rhinitis (16 years and older). Background information on allergic rhinitis, severity of allergic rhinitis symptoms and their impact on lives, nonmedical measures for relieving of symptoms, types of medications, and concomitant conditions were evaluated.

Recent Findings: Almost 50% of the responders reported symptoms lasting for more than a season. Preventive household adjustments are expensive with little perceived benefit. Sleep and emotional life are affected by allergic rhinitis. Most patients are satisfied with the current allergic rhinitis medications; at least one-fifth report dissatisfaction. Patients perceive that allergic rhinitis worsens other concomitant allergic diseases.

Summary: Future management guidelines for allergic rhinitis must take into account the results of this survey. Such guidelines must promote relief from the emotional burden of allergic rhinitis and from the negative impact on daily activities, encourage patient education, and maintain and build on the strong partnership between patients and healthcare professionals.

Citing Articles

Survey on Treatment-Seeking Patterns in Patients With Allergic Rhinitis.

Ryu G, Kim D, Jeong C, Lee S, Lee I, Kim S J Rhinol. 2025; 31(3):138-144.

PMID: 39744453 PMC: 11685916. DOI: 10.18787/jr.2024.00023.


The burden of allergic rhinitis is undermanaged in a large proportion of Chinese young adults from Singapore.

Wong Q, Lim J, Ng J, Malipeddi P, Lim Y, Sio Y World Allergy Organ J. 2024; 17(9):100954.

PMID: 39228765 PMC: 11367507. DOI: 10.1016/j.waojou.2024.100954.


An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu in Austrian Patients with Persistent Allergic Rhinitis.

Marth K, Renner A, Langmayr G, Pohl W, Nguyen D, Kuhl H Drugs Real World Outcomes. 2024; 11(2):231-240.

PMID: 38351402 PMC: 11176283. DOI: 10.1007/s40801-023-00412-z.


Allergic rhinitis facts from an Irish pediatric population.

Nae A, Heffernan C, Colreavy M World J Otorhinolaryngol Head Neck Surg. 2023; 9(4):333-339.

PMID: 38059143 PMC: 10696270. DOI: 10.1002/wjo2.105.


Real-Life Effectiveness of MP-AzeFlu (Dymista) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale.

Stjarne P, Nguyen D, Kuhl H Pragmat Obs Res. 2023; 14:1-11.

PMID: 36628265 PMC: 9826638. DOI: 10.2147/POR.S375403.